...
首页> 外文期刊>Microbial drug resistance: MDR : Mechanisms, epidemiology, and disease >Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India
【24h】

Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India

机译:来自印度北部三级医院的嗜麦芽窄食单胞菌临床分离株中1类整合素,sul1和sul2基因的分布

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Stenotrophomonas maltophilia is an emerging nosocomial pathogen responsible for serious human infections. This study was carried out to determine antibiotic susceptibility, resistance mechanisms (integrons, sul1 and sul2), and genetic relatedness (Enterobacterial Repetitive Intergenic Consensus [ERIC]-PCR) among 106 clinical isolates of S. maltophilia from India. Twenty-four (22.6%) of S. maltophilia isolates exhibited resistance to mainstay antibiotic trimethoprim-sulfamethoxazole (TMP-SMX). Except for 2 isolates which contained both TMP-SMX resistance determinants sul1 and sul2 genes, all other 22 TMP-SMX-resistant isolates carried either sul1 (10 isolates) or sul2 (12 isolates) genes. Class 1 integrons were present in 8.5% (9 out of 106) of S. maltophilia isolates, and only 5 out of these isolates were TMP-SMX resistant and positive for sul1 gene. The same isolates also carried resistance cassettes containing qac/smr gene. Minocycline and levofloxacin exhibited the maximum in vitro activity against S. maltophilia. ERIC-PCR revealed high diversity among S. maltophilia isolates. The present study demonstrated high (22.4%) TMP-SMX resistance in clinical isolates of S. maltophilia from India. TMP-SMX-resistant isolates carried relatively higher percentage of sul2 gene than sul1 gene as against the reported literature. Majority (58.3%) of sul1 gene positive were not associated with class 1 integrase gene.
机译:嗜麦芽窄食单胞菌是一种新兴的医院内病原体,可引起严重的人类感染。这项研究的目的是确定印度106名嗜麦芽胞菌临床分离株中的抗生素敏感性,耐药机制(整合子,sul1和sul2)和遗传相关性(肠细菌重复性基因间共识[ERIC] -PCR)。二十四个(22.6%)的嗜麦芽孢杆菌分离株表现出对主流抗生素甲氧苄啶-磺胺甲基异恶唑(TMP-SMX)的抗性。除2个同时包含TMP-SMX抗性决定簇sul1和sul2基因的分离株外,所有其他22个TMP-SMX抗性分离株均携带sul1(10个分离株)或sul2(12个分离株)基因。 1%整合素存在于8.5%(106个中的9个)嗜麦芽孢杆菌分离株中,而这些分离株中只有5个对TMP-SMX具有抗性并且对sul1基因呈阳性。同样的分离物还携带了含有qac / smr基因的抗性盒。米诺环素和左氧氟沙星显示出最大的抗嗜麦芽糖链球菌的体外活性。 ERIC-PCR显示嗜麦芽孢杆菌分离株之间具有高度多样性。本研究表明,来自印度的嗜麦芽孢杆菌临床分离株对TMP-SMX的耐药性较高(22.4%)。与报道的文献相比,抗TMP-SMX的分离株携带的sul2基因百分比高于sul1基因百分比。 sul1基因阳性的多数(58.3%)与1类整合酶基因无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号